¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"oxidation reduction potential"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nitrate reduction
    Áú»ê¿°È¯¿ø
  • open reduction
    °³¹æÁ¤º¹(¼ú)
  • proportional reduction
    ºñ·Ê°¨¼Ò
  • reduction
    1. ¸ÂÃã, ±³Á¤, Á¤º¹(¼ú) 2. ȯ¿ø 3. Ãà¼Ò(¼ú) 4. ¾àºÐ
  • reduction division
    °¨¼öºÐ¿­
  • reduction rhinoplasty
    ÄÚÃà¼Ò(¼ú), Ãà¼ÒÄÚ¼ºÇü(¼ú)
  • scalp reduction
    ¸Ó¸®µ¤°³Ãà¼Ò(¼ú), µÎÇÇÃà¼Ò(¼ú)
  • stress-reduction technique
    ½ºÆ®·¹½º°¨¼Ò±â¹ý
  • silver reduction method
    ÀºÈ¯¿ø¹ý
  • auditory evoked potential
    µè±âÀ¯¹ßÀüÀ§, û°¢À¯¹ßÀüÀ§
  • action potential
    Ȱµ¿ÀüÀ§
  • biphasic action potential
    ÀÌ»ó¼ºÈ°µ¿ÀüÀ§
  • brain stem evoked potential
    ³úÁÙ±âÀ¯¹ßÀüÀ§
  • cognitive evoked potential
    ÀνÄÀ¯¹ßÀüÀ§
  • complex potential
    º¹ÇÕÀüÀ§
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cortical evoked potential
    °ÑÁúÀ¯¹ßÀüÀ§, ÇÇÁúÀ¯¹ßÀüÀ§
  • evoked potential
    À¯¹ßÀüÀ§
  • membrane potential
    ¸·ÀüÀ§
  • reversal potential
    ¿ªÀüÀüÀ§, ¿ªÀüÀü¾Ð
  • transmembrane potential
    ¸·ÀüÀ§, ¸·Àü¾Ð
  • potential surface
    ÀüÀ§¸é
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mandibular angle reduction
    ÅλÀ°¢Ãà¼Ò¼ú, ÇϾǰ¢Ãà¼Ò¼ú
  • silver reduction method
    ÀºÈ¯¿ø¹ý
  • nitrate reduction
    Áú»ê¿°È¯¿ø
  • open reduction
    °³¹æ°ñÀý±³Á¤, ¿­¸²µÇ¸ÂÃã¼ú
  • proportional reduction
    ºñ·Ê°¨·Â
  • reduction
    ±³Á¤, ȯ¿ø, Ãà¼Ò
  • reduction rhinoplasty
    ÄÚÃà¼Ò¼ú, Ãà¼ÒÄÚ¼ºÇü¼ú
  • reduction semiconductor
    ȯ¿øÇü¹ÝµµÃ¼
  • reduction test
    ȯ¿ø½ÃÇè
  • scalp reduction
    ¸Ó¸®µ¤°³Ãà¼Ò¼ú, µÎÇÇÃà¼Ò¼ú
  • stress-reduction technique
    ½ºÆ®·¹½º°¨¼Ò±â¹ý
  • action potential
    Ȱµ¿ÀüÀ§
  • auditory evoked potential
    û°¢À¯¹ßÀüÀ§
  • biphasic action potential
    ÀÌ»óȰµ¿ÀüÀ§
  • brain stem evoked potential
    ³úÁÙ±âÀ¯¹ßÀüÀ§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reduction of fraction
    ¾àºÐ(å³ÝÂ).
  • reduction of fracture
    °ñÀý Á¤º¹(Íéï¹ïÚÜÖ).
  • reduction rhinoplasty
    Ãà¼Òºñ¼ºÇü¼ú
  • reduction semiconductor
    ȯ¿øÇü¹ÝµµÃ¼(ü½êªû¡ÚâÓôô÷).
  • reduction test
    ȯ¿ø½ÃÇè.
  • EP =endocochlear potential
    ¿Í¿ì³»(Á÷·ù)ÀüÀ§
  • EPSP (excitatory postsynaptic potential)
    ÈïºÐ¼º(ýéÝÇàõ)½Ã³³½ºÈÄ(ý­)ÀüÀ§(ï³êÈ), ÈïºÐ¼º ¿¬Á¢(Ö§ïÈ)ÀüÀ§
  • Generator potential
    ±âµ¿ÀüÀ§(ÑÃÔÑï³êÈ)
  • IPSP = inhibitory postsynaptic potential
    ¾ïÁ¦¼º(åäð¤àõ)½Ã³À½ºÈÄ(ý­)Àü¾Ð(ï³äâ)
  • Intraneuronal potential
    ½Å°æ³»ÀüÀ§(ãêÌèÒ®ï³êÈ)
  • Junctional potential
    Á¢ÇÕºÎÀüÀ§(ïÈùêݬï³êÈ)
  • Local potential
    ±¹¼ÒÀüÀ§(ÏÑá¶ï³êÈ)
  • MEPP=>miniature end plate potential
    ¹Ì¼¼Á¾ÆÇÀü¾Ð
  • MEPP=£¾miniature end plate potential
    ¹Ì¼¼Á¾ÆÇÀüÀ§.
  • RP=£¾resting potential
    Á¤ÁöÀüÀ§.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • oxidation fermentation test
    »êÈ­¹ßÈ¿½ÃÇè.
  • oxidation pond
    »êÈ­Áö(ß«ûùò®).
  • oxidation theory
    »êÈ­¼³(ß«ûùæò).
  • oxidation velocity
    »êÈ­¼Óµµ(ß«ûùáÜöô).
  • oxidation-fermentation medium
    »êÈ­-¹ßÈ¿¹èÁö
  • oxidizing enzyme =oxidation e.
    »êÈ­È¿¼Ò (¡­ý£áÈ).
  • periodate oxidation
    °ú¿Á¼Ò»ê¿°»êÈ­
  • total oxidation process
    ¿ÏÀü»êÈ­¹ý(èÇîïß« ûùÛö).
  • closed reduction
    µµ¼öÁ¤º¹(Óùâ¢ïÚÜÙ), ºñ°üÇ÷Àû(°ñ)Á¤º¹¼ú(ުκúìîÜÍéïÚÜÖâú).
  • copper reduction test
    ±¸¸®È¯¿ø½ÃÇè
  • dose-reduction factor
    ¼±·®°¨¼Ò°è¼ö
  • false reduction
    °¡ ȯ³³(Ê£ü½Ò¡), °¡ Á¤º¹.
  • methylene blue reduction test
    ¸ÞÆ¿·»ºí·ç ¿ìȯ¿ø½ÃÇè(¡­ü»êªãËúÐ).
  • nitrate reduction
    Áú»ê¿°È¯¿ø(òòß«ç¤ü½êª).
  • nitrate reduction test
    Áú»ê¿°È¯¿ø½ÃÇè(~ãËúÐ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reduction division
    °¨¼öºÐ¿­(Êõâ¦ÝÂæñ)
  • reduction phase
    ȯ¿ø±â(ü½êªÑ¢)
  • respiratory reduction
    È£Èí¼º ȯ¿ø(û¼ýåàõü½êª)
  • sulfate reduction
    Ȳ»êȯ¿ø(üÜß«ü½êª)
  • beta oxidation
    º£Å¸ »êÈ­(ß«ûù)
  • complete oxidation
    ¿ÏÀü»êÈ­(èÇîïß«ûù)
  • direct oxidation pathway
    "Á÷Á¢»êÈ­°æ·Î(òÁïÈß«ûùÌèÖØ), (ÔÒ) hexose monophosphate shunt"
  • fatty acid oxidation
    Áö¹æ»ê »êÈ­ (ò·Û¸ß«ß«ûù)
  • glucuronic acid oxidation pathway
    ±Û·çÅ¥·Ð»ê(ß«) »êÈ­°æ·Î(ß«ûùÌèÖØ)
  • incomplete oxidation
    ºÒ¿ÏÀü »êÈ­(ÝÕèÇîïß«ûù)
  • Meyerhof oxidation quotient
    ¸¶À̾îÈ£ÇÁ »êÈ­»ó(ß«ûùßÂ)
  • omega oxidation
    ¿À¸Þ°¡ »êÈ­(ß«ûù)
  • oxidation
    »êÈ­(ß«ûù)
  • oxidation number
    »êÈ­ ¼ö(ß«ûùâ¦)
  • oxidation quotient
    »êÈ­ »ó(ß«ûùßÂ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DRP digoxin reduction product; dorsal root potential; dystrophin-related protein
GOQ glucose oxidation quotient
MOF marine oxidation/fermentation; methotrexate, Oncovin, and fluorouracil; multiple organ failure
OF occipitofrontal; open field [test]; optical fundus; orbitofrontal; osmotic fragility; osteitis fibro...
O/F oxidation-fermentation
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MCO Metal-catalyzed oxidation
FRO free radical oxidation
POL peroxide oxidation of lipids
ARR Absolute risk reduction
CFR Cyclic flow reduction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • interproximal reduction
    Ä¡°£ »èÁ¦
  • nitrate reduction test
    Áú»ê¿° ȯ¿ø ½ÃÇè
  • reduction of fracture
    °ñÀý Á¤º¹
  • silver reduction method
    Àº ȯ¿ø¹ý
  • TMJ-ID with reduction
    Á¤º¹¼º ¾Ç°üÀý ³»Àå
    ¾Ç°üÀý ³»ÀåÀÇ Ãʱ⠴ܰè·Î ¿Õº¹¼º °üÀýÀ½ÀÌ Æ¯Â¡À¸·Î ³ªÅ¸³­´Ù. ÇÏ¾Ç ¿îµ¿ ¹üÀ§´Â ´ë°³ Á¤»óÀÌ´Ù.
  • absolute potential
    Àý´ë Àü¾Ð, Àý´ë ÀüÀ§
  • action potential
    Ȱµ¿ ÀüÀ§, Ȱµ¿ Àü¾Ð
    ±ÙÀ°¼¼Æ÷ ¶Ç´Â ½Å°æ¼¼Æ÷°¡ ÈïºÐÇÒ ¶§ »ý±â´Â Àü±âÀû Ȱ¼ºÀ¸·Î¼­, Àü±âÀû, È­ÇÐÀû, ±â°èÀû ÀÚ±Ø ¹× ¿Âµµº¯È­ µî¿¡ ÀÇÇÏ¿© »ý±ä´Ù°í »ý°¢Çϰí ÀÖ´Ù.
  • adaptive potential
    ÀûÀÀ ÀáÀç·Â
    µ¿ÀǾî=ada
  • after-potential
    ÈÄ ÀüÀ§ Çö»ó
    ½ºÆÄÀÌÅ© ÀüÀ§ µÚ¿¡ º¼ ¼ö ÀÖ´Â ÀüÀ§ º¯µ¿ÀÌ´Ù. À½¼º ÈÄ ÀüÀ§¿Í ¾ç¼º ÈÄ ÀüÀ§·Î ³ª´¶´Ù. ÀüÀÚ´Â ¿ªÄ¡ÀÇ »ó½Â, ÈÄÀÚ´Â Çϰ­À» ÀÏÀ¸Å²´Ù.
  • body surface potential mapping
    üǥ¸é ÀüÀ§µµ
  • chemical potential
    È­ÇÐ ÀüÀ§, È­ÇÐ Æ÷ÅÙ¼³
  • compound action potential
    º¹ÇÕ È°µ¿ Àü¾Ð
  • contact potential difference
    Á¢ÃË ÀüÀ§Â÷
  • disability potential
    Àå¾ÖÀÇ ÀáÀ缺
  • dorsal root potential
    Èı٠Àü¾Ð
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
omega-oxidation Oxidation at the carbon atom farthest removed (ω-carbon) from the carboxyl group (carbon 1); thus, in this pathway, a dicarboxylic acid is formed; an important pathway in the degradation of prostaglandins.
(05 Mar 2000)
omega-oxidation theory That the oxidation of fatty acids commences at the CH3 group, i.e., the terminal or omega-group; beta-oxidation then proceeds at both ends of the fatty acid chain.
(05 Mar 2000)
oxidation <biochemistry> The process whereby fatty acids are degraded in steps, losing 2 carbons as (acetyl) CoA. Involves CoA ester formation, desaturation, hydroxylation and oxidation before each cleavage.
(18 Nov 1997)
oxidation-fermentation test <investigation> A test to to determine whether a given bacterial strain has an oxidative or fermentativetype of metabolism by seeing what it doesto a carbohydrate substrate.
(09 Oct 1997)
oxidation number The number of electrons necessary to restore an atom in a combined state to its elemental form.
(09 Oct 1997)
oxidation pond A pond that contains partially treated wastewater which is then left to allow the growth of algae and bacteria which decompose therest of the waste.
(09 Oct 1997)
terminal oxidation <biochemistry> The last oxidation step in a catabolic pathway.
Synonym: terminal oxidation.
(05 Mar 2000)
end oxidation <biochemistry> The last oxidation step in a catabolic pathway.
Synonym: terminal oxidation.
(05 Mar 2000)
fatty acid oxidation cycle A series of reactions involving acyl-coenzyme A compounds, whereby these undergo beta oxidation and thioclastic cleavage, with the formation of acetyl-coenzyme A; the major pathway of fatty acid catabolism in living tissue.
(05 Mar 2000)
acetyl reduction assay <investigation> A technique for measuring the nitrogen fixation activity in photosynthetic organisms. It uses a flame ionisation detector and a gas chromatography apparatus to determine the reduction of acetylene to ethylene by the enzyme nitrogenase.
(06 May 1997)
reduction <orthopaedics, surgery> The correction of a fracture, dislocation or hernia.
(18 Nov 1997)
reduction deformity Congenital absence or attenuation of one or more body parts; usually of the limbs or limb components.
(05 Mar 2000)
reduction division The first cell division in meiosis, the process by which germ cells are formed. A unique event in which the chromosome number is reduced from diploid (46 chromosomes) to haploid (23 chromosomes). Also called first meiotic division or first meiosis.
(12 Dec 1998)
reduction en masse Reduction of hernial sac and contents, so that intestinal obstruction is still present.
(05 Mar 2000)
reduction mammaplasty Plastic surgery of the breast to reduce its size and (frequently) to improve its shape and position.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • potential transformer
    °è±â¿ëº¯¾Ð±â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á